Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis

Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS). Methods: A total of 117 patients without underlying heart disease who were not taking antiplatelet drugs had early r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yun Ho Noh, Ji Young Lee, Seok Mann Yoon, Yu Jin Ha, Jaewoo Chung, Jung Ho Ko, Dong Seong Shin, Jae-Min Ahn, Hyuk Jin Oh, Jai-Joon Shim, Man Ryul Lee, Jae Sang Oh
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/47b0c407d9c94d2297294d7b6b882c0d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:47b0c407d9c94d2297294d7b6b882c0d
record_format dspace
spelling oai:doaj.org-article:47b0c407d9c94d2297294d7b6b882c0d2021-11-30T04:16:09ZEfficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis2214-751910.1016/j.inat.2021.101425https://doaj.org/article/47b0c407d9c94d2297294d7b6b882c0d2022-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214751921003376https://doaj.org/toc/2214-7519Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS). Methods: A total of 117 patients without underlying heart disease who were not taking antiplatelet drugs had early reocclusion during MT for ELVO due to ICAS. They were divided into the following 3 groups according to rescue treatment methods: 1) Combined intravenous (IV) + intra-arterial (IA) tirofiban group (n = 48), emergent percutaneous transluminal angioplasty (PTA) and intracranial stenting (ICS) followed by IA injection of tirofiban and a continuous IV tirofiban infusion for 8 h; 2) IA tirofiban group (n = 33), only IA 0.5–1.0 mg tirofiban infusion for 5 min regardless of PTA or ICS; and 3) no tirofiban group (n = 36), no tirofiban injection regardless of PTA or ICS. Results: ICS was more frequently performed in the combined IV + IA tirofiban group than in the IA tirofiban group (100% vs 46%, p < 0.05). The proportion of m-TICI grades 2b and 3 (93.8% vs. 63.6%, p < 0.05), especially the proportion of m-TICI grade 3 (81.3% vs. 36.4%, p < 0.05), was higher in the combined IV + IA tirofiban group than in the IA tirofiban group. The rate of postoperative intracranial hemorrhage was not significantly different among the three groups. The rate of modified Rankin scale scores of 0–2 at 3 months after MT was highest in the combined IV + IA tirofiban group (63%), followed by the IA tirofiban (46%) and no tirofiban groups (8%, p < 0.05). Conclusion: ICS with IA and continuous IV tirofiban injections for 8 h is an effective and safe protocol for failed MT in patients with ELVO with ICAS.Yun Ho NohJi Young LeeSeok Mann YoonYu Jin HaJaewoo ChungJung Ho KoDong Seong ShinJae-Min AhnHyuk Jin OhJai-Joon ShimMan Ryul LeeJae Sang OhElsevierarticleIschemic strokeIntracranial arteriosclerosisThrombectomyThrombosisTirofibanSurgeryRD1-811Neurology. Diseases of the nervous systemRC346-429ENInterdisciplinary Neurosurgery, Vol 27, Iss , Pp 101425- (2022)
institution DOAJ
collection DOAJ
language EN
topic Ischemic stroke
Intracranial arteriosclerosis
Thrombectomy
Thrombosis
Tirofiban
Surgery
RD1-811
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Ischemic stroke
Intracranial arteriosclerosis
Thrombectomy
Thrombosis
Tirofiban
Surgery
RD1-811
Neurology. Diseases of the nervous system
RC346-429
Yun Ho Noh
Ji Young Lee
Seok Mann Yoon
Yu Jin Ha
Jaewoo Chung
Jung Ho Ko
Dong Seong Shin
Jae-Min Ahn
Hyuk Jin Oh
Jai-Joon Shim
Man Ryul Lee
Jae Sang Oh
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
description Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS). Methods: A total of 117 patients without underlying heart disease who were not taking antiplatelet drugs had early reocclusion during MT for ELVO due to ICAS. They were divided into the following 3 groups according to rescue treatment methods: 1) Combined intravenous (IV) + intra-arterial (IA) tirofiban group (n = 48), emergent percutaneous transluminal angioplasty (PTA) and intracranial stenting (ICS) followed by IA injection of tirofiban and a continuous IV tirofiban infusion for 8 h; 2) IA tirofiban group (n = 33), only IA 0.5–1.0 mg tirofiban infusion for 5 min regardless of PTA or ICS; and 3) no tirofiban group (n = 36), no tirofiban injection regardless of PTA or ICS. Results: ICS was more frequently performed in the combined IV + IA tirofiban group than in the IA tirofiban group (100% vs 46%, p < 0.05). The proportion of m-TICI grades 2b and 3 (93.8% vs. 63.6%, p < 0.05), especially the proportion of m-TICI grade 3 (81.3% vs. 36.4%, p < 0.05), was higher in the combined IV + IA tirofiban group than in the IA tirofiban group. The rate of postoperative intracranial hemorrhage was not significantly different among the three groups. The rate of modified Rankin scale scores of 0–2 at 3 months after MT was highest in the combined IV + IA tirofiban group (63%), followed by the IA tirofiban (46%) and no tirofiban groups (8%, p < 0.05). Conclusion: ICS with IA and continuous IV tirofiban injections for 8 h is an effective and safe protocol for failed MT in patients with ELVO with ICAS.
format article
author Yun Ho Noh
Ji Young Lee
Seok Mann Yoon
Yu Jin Ha
Jaewoo Chung
Jung Ho Ko
Dong Seong Shin
Jae-Min Ahn
Hyuk Jin Oh
Jai-Joon Shim
Man Ryul Lee
Jae Sang Oh
author_facet Yun Ho Noh
Ji Young Lee
Seok Mann Yoon
Yu Jin Ha
Jaewoo Chung
Jung Ho Ko
Dong Seong Shin
Jae-Min Ahn
Hyuk Jin Oh
Jai-Joon Shim
Man Ryul Lee
Jae Sang Oh
author_sort Yun Ho Noh
title Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
title_short Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
title_full Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
title_fullStr Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
title_full_unstemmed Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
title_sort efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
publisher Elsevier
publishDate 2022
url https://doaj.org/article/47b0c407d9c94d2297294d7b6b882c0d
work_keys_str_mv AT yunhonoh efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT jiyounglee efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT seokmannyoon efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT yujinha efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT jaewoochung efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT junghoko efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT dongseongshin efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT jaeminahn efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT hyukjinoh efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT jaijoonshim efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT manryullee efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
AT jaesangoh efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis
_version_ 1718406799147663360